Zobrazeno 1 - 10
of 348
pro vyhledávání: '"Liang Huang"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background MCD (MYD88L265P/CD79Bmut) diffuse large B‐cell lymphoma has a poor prognosis. There is no published clinical research conclusion regarding zanubrutinib or orelabrutinib for the initial treatment of MCD DLBCL. Aims This study aim
Externí odkaz:
https://doaj.org/article/e6f6962cbfdf4d91b50c49156906488b
Autor:
Wenfeng Liang, Haiqing Jie, Hao Xie, Yebohao Zhou, Wenxin Li, Liang Huang, Zhenxing Liang, Huashan Liu, Xiaobin Zheng, Ziwei Zeng, Liang Kang
Publikováno v:
Clinical & Translational Immunology, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Objectives Emerging evidence has demonstrated that tumour budding (TB) is negatively associated with T‐lymphocyte infiltration in CRC. Despite extensive research, the molecular characteristics of immunologically ‘hot’ TB remain poorly
Externí odkaz:
https://doaj.org/article/b99a3b9940924e6c8e8203c49b10fafa
Autor:
Qi Zhang, Chunrui Li, Yang Cao, Na Wang, Liang Huang, Zhen Shang, Jue Wang, Lifang Huang, Jinhuan Xu, Min Xiao, Liting Chen, Xiaojian Zhu, Yicheng Zhang, Yi Xiao
Publikováno v:
Clinical Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Key Clinical Message Immune checkpoint inhibitors are a very popular method of treating malignant tumors. But its side effects cannot be ignored. This study revealed obstructive complications during immune consolidation therapy following sequential c
Externí odkaz:
https://doaj.org/article/8ed284be114040fcbdde84c9bdce7299
Publikováno v:
HemaSphere, Vol 7, p e6853518 (2023)
Externí odkaz:
https://doaj.org/article/cfb55da483994481b196062192fa3180
Publikováno v:
HemaSphere, Vol 7, p e3575455 (2023)
Externí odkaz:
https://doaj.org/article/cf142f4369ee498d9d0f8a68752e0057
Autor:
Jiali Nie, Li Yang, Liang Huang, Lili Gao, Ken He Young, Jehane Michael Le Grange, Xingcheng Yang, Jia Wei, Min Xiao, Jianfeng Zhou
Publikováno v:
Cancer Communications, Vol 42, Iss 5, Pp 476-480 (2022)
Externí odkaz:
https://doaj.org/article/866ddc13e0704e0285e6e87532b0e9cb
Autor:
Huashan Liu, Zhenxing Liang, Sijing Cheng, Liang Huang, Wenxin Li, Chi Zhou, Xiaobin Zheng, Shujuan Li, Ziwei Zeng, Liang Kang
Publikováno v:
Advanced Science, Vol 10, Iss 6, Pp n/a-n/a (2023)
Abstract The roles of oncogenic KRAS in tumor immune evasion remain poorly understood. Here, mutant KRAS is identified as a key driver of tumor immune evasion in colorectal cancer (CRC). In human CRC specimens, a significant reduction in cytotoxic CD
Externí odkaz:
https://doaj.org/article/3a6a099b6f4244b6a491a210edd9fb72
Publikováno v:
IET Energy Systems Integration, Vol 3, Iss 4, Pp 508-519 (2021)
Abstract Electric vehicles (EVs) have excellent demand response potential, but a single type of demand response is difficult to fully utilise the dispatching potential of EVs. To improve the utilisation of the demand response potential of EVs, this s
Externí odkaz:
https://doaj.org/article/5fe5fba191dc41faa5a24093068065d8
Publikováno v:
Energy Conversion and Economics, Vol 2, Iss 3, Pp 122-132 (2021)
Abstract Standalone multi‐energy hub is the next frontier of electric grid modernization. It is vital to optimize the standalone multi‐energy hub capacity configuration to enhance the hub reliability, economic efficiency, and sustainability. Ther
Externí odkaz:
https://doaj.org/article/de34e5fee3c74403bd16d5550cccc626
Publikováno v:
Advanced Science, Vol 8, Iss 24, Pp n/a-n/a (2021)
Abstract Electrochemical CO2 reduction to value‐added chemicals/fuels provides a promising way to mitigate CO2 emission and alleviate energy shortage. CO2‐to‐CO conversion involves only two‐electron/proton transfer and thus is kinetically fas
Externí odkaz:
https://doaj.org/article/2f7f9280d27d42d08ffa931635a299cc